Literature DB >> 21442725

Elastin-like recombinamers as substrates for retinal pigment epithelial cell growth.

Girish K Srivastava1, Laura Martín, Amar K Singh, Ivan Fernandez-Bueno, Manuel J Gayoso, Maria T Garcia-Gutierrez, Alessandra Girotti, Matilde Alonso, José C Rodríguez-Cabello, José C Pastor.   

Abstract

The aim of this study is to investigate the use of elastin-like recombinamers (ELRs) as a substrate that can maintain the growth, phenotype, and functional characteristics of retinal pigment epithelial (RPE) cells efficiently and as a suitable carrier for the transplantation of autologous RPE cells for treatment of age-related macular degeneration (AMD). ELR films containing a bioactive sequence, RGD (ELR-RGD), and one with no specific sequence (ELR-IK) as control, were obtained by solvent-casting onto glass and subsequent cross-linking. ARPE19 cells were seeded on sterilized ELR films as well as on the control surfaces. Cells were analysed after 4, 24, 72, and 120 h to study cell adhesion, proliferation, cell viability, morphology, and specificity by staining with Trypan blue, DAPI, Rhodamin-Phalloidin and RPE65, ZO-1 antibodies and observing under fluorescence as well as electron microscope. ARPE19 cells seeded on both ELR films and controls were 100% viable and maintained their morphology and set of characteristics at the different time points studied. Cell proliferation on ELR-RGD was significantly higher than that found on ELR-IK at all time points, although it was less than the growth rate on polystyrene. ARPE19 cells grow well on ELR-RGD maintaining their phenotype. These results should be extended to further studies with fresh human RPE cells and in vivo studies to determine whether this ELR-RGD matrix could be used as a Bruch's membrane prosthesis and carrier for transplantation of RPE cells in patients suffering with AMD.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442725     DOI: 10.1002/jbm.a.33050

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

1.  Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth.

Authors:  Gisele Rodrigues Da Silva; Armando Da Silva-Cunha; Lorena Carla Vieira; Lívia Mara Silva; Eliane Ayres; Rodrigo Lambert Oréfice; Silvia Ligório Fialho; Juliana Barbosa Saliba; Francine Behar-Cohen
Journal:  J Mater Sci Mater Med       Date:  2013-02-22       Impact factor: 3.896

2.  Regenerating Retinal Pigment Epithelial Cells to Cure Blindness: A Road Towards Personalized Artificial Tissue.

Authors:  Balendu Shekhar Jha; Kapil Bharti
Journal:  Curr Stem Cell Rep       Date:  2015-06

3.  The influences of purple sweet potato anthocyanin on the growth characteristics of human retinal pigment epithelial cells.

Authors:  Min Sun; Xiaoling Lu; Lei Hao; Tao Wu; Huanjiao Zhao; Chao Wang
Journal:  Food Nutr Res       Date:  2015-06-11       Impact factor: 3.894

4.  Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation.

Authors:  Girish K Srivastava; David Rodriguez-Crespo; Amar K Singh; Clara Casado-Coterillo; Ivan Fernandez-Bueno; Maria T Garcia-Gutierrez; Joaquin Coronas; J Carlos Pastor
Journal:  Biomed Res Int       Date:  2014-02-02       Impact factor: 3.411

Review 5.  Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies.

Authors:  Nahla Jemni-Damer; Atocha Guedan-Duran; María Fuentes-Andion; Nora Serrano-Bengoechea; Nuria Alfageme-Lopez; Félix Armada-Maresca; Gustavo V Guinea; José Perez-Rigueiro; Francisco Rojo; Daniel Gonzalez-Nieto; David L Kaplan; Fivos Panetsos
Journal:  Front Bioeng Biotechnol       Date:  2020-12-10

6.  Towards an In Vitro Retinal Model to Study and Develop New Therapies for Age-Related Macular Degeneration.

Authors:  Beatrice Belgio; Federica Boschetti; Sara Mantero
Journal:  Bioengineering (Basel)       Date:  2021-01-22

7.  Application of elastin-mimetic recombinant proteins in chemotherapeutics delivery, cellular engineering, and regenerative medicine.

Authors:  Won Bae Jeon
Journal:  Bioengineered       Date:  2013-03-08       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.